Skip to content

Oral montelukast versus inhaled steroids for mild persistent asthma among 1 to 5 year old children

Oral montelukast versus inhaled steroids for mild persistent asthma among 1 to 5 year old children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2011/006
Enrollment
Unknown
Registered
2011-05-20
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial Asthma

Interventions

Children who fulfill the criteria will be selected after a preliminary inquiry by a trained interviewers and they will be enlisted for the study. Every parent will be educated by a trained medical per

Sponsors

Getz Pharma (Pvt) Limited
Lead Sponsor
Citi Health Import Pvt ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Children between 1-5 yrs of age Symptoms of cough variant asthma persisting for more than 2 months

Exclusion criteria

Exclusion criteria: Premature birth (3 in the past) Previous use of any preventers

Design outcomes

Primary

MeasureTime frame
Improvement of asthma symptoms detected by reduction of Asthma score [4 months after the study (at the end of the study)]

Secondary

MeasureTime frame
Reduction of frequency of using beta agonists, Reduction of number of hospital admissions, Reduction of number of school absenteeism, Improvement of allergic rhinitis [4 months after the study (at the end of the study) ]

Countries

Sri Lanka

Contacts

Public ContactDr. (Mrs.) P. P. Jayawardena

Consultant Paediatrician , Senior Lecturer

pushpikaja@yahoo.com.au0914924263

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026